Skip to content

Gelweave™ 734028/10ADPRecalls & reported problems

Vascutek Ltd · Gelweave Gelatin Impregnated Woven Vascular Prosthesis VALSALVA ANTE-FLO · Class 2 · Implant

All models of Gelweave (47)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
4
Deaths reported
0
Injuries reported
3
Recalls naming it
0

Summary

The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 05037881121031), received between Jul 13, 2017 and Oct 30, 2019 — classified as 3 injuries, 1 malfunction.

The most frequently reported specific device problem is “Device Operates Differently Than Expected” (3 reports).

1 other recall cover devices cleared under the same FDA submission (K090987); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Device Operates Differently Than Expected3
  • Material Integrity Problem1
  • Material Puncture/Hole1

Patient problems

  • Fever3
  • Seroma3
  • No Known Impact Or Consequence To Patient1

Recent adverse event reports

The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.

  • MalfunctionOct 30, 2019Material Puncture/Hole; Material Integrity Problem; Material Puncture/Hole; Material Integrity Problem

    THE EVENT WAS REPORTED AS FOLLOWS: WHEN THE PHYSICIAN WAS ANASTOMOSING THE DISTAL END OF THE GRAFT, THE PHYSICIAN OBSERVED THAT THE GRAFT HAD A HOLE WHICH WAS MUCH BIGGER THAN A PIN HOLE. THE PHYSICIAN SUTURED THE HOLE. THE PROCEDURE WAS SUCCESSFULLY COMPLETED.

    Patient problems: No Known Impact Or Consequence To Patient

    MAUDE report 9254300 ↗
  • InjuryJul 13, 2017Device Operates Differently Than Expected; Device Operates Differently Than Expected

    VASCUTEK HAVE RECEIVED NOTIFICATION OF THE EVENT THAT WAS DESCRIBED AS 39-DEGREE FEVER ONE WEEK AFTER THE IMPLANT DAY. A SEROMA AROUND THE IMPLANTED GRAFT WAS OBSERVED AS WELL. INITIALLY PROCEDURE WAS COMPLETE AS USUAL. THE PATIENT IS IN CLINICAL FOLLOW-UP STAGE AND IS ON THE WAY TO RECOVERY.

    Patient problems: Fever; Seroma

    MAUDE report 6710368 ↗
  • InjuryJul 13, 2017Device Operates Differently Than Expected; Device Operates Differently Than Expected

    VASCUTEK HAVE RECEIVED NOTIFICATION OF THE EVENT THAT WAS DESCRIBED AS 39-DEGREE FEVER AFTER SEVERAL DAYS FROM THE IMPLANT DAY. A SEROMA AROUND THE IMPLANTED GRAFT WAS OBSERVED AS WELL. INITIALLY PROCEDURE WAS COMPLETE AS USUAL. PATIENT WAS GIVEN ANTIPYRETIC TO REDUCE THE FEVER AND IS IN THE RECOVERY.

    Patient problems: Fever; Seroma

    MAUDE report 6710366 ↗
  • InjuryJul 13, 2017Device Operates Differently Than Expected; Device Operates Differently Than Expected

    VASCUTEK HAVE RECEIVED NOTIFICATION OF THE EVENT THAT WAS DESCRIBED AS 39-DEGREE FEVER AFTER SEVERAL DAYS FROM THE IMPLANT DAY. A SEROMA AROUND THE IMPLANTED GRAFT WAS OBSERVED AS WELL. INITIALLY PROCEDURE WAS COMPLETE AS USUAL. PATIENT WAS GIVEN ANTIPYRETIC TO REDUCE THE FEVER AND IS IN THE RECOVERY.

    Patient problems: Fever; Seroma

    MAUDE report 6710362 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under K090987. One submission often covers many models, so check the product and lot details in each record.

  • Z-2542-2021 · Jul 8, 2021 · Terminated
    The Instructions for Use (IFU) for: Gelsoft Plus Bifurcate, Gelsoft Plus Ax-Fem, GelsoftPlus ERS Ax-Fem, Gelweave Straight, Gelweave Trifurcate, Gelweave Ant-Flo, and Gelweave Val

Other PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER devices

All PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page